| Mrs Stephanie Michelle Pizarro, RN | |
|
3200 23rd Ave S, Seattle, WA 98144-6432 | |
| (206) 252-7285 | |
| Not Available |
| Full Name | Mrs Stephanie Michelle Pizarro |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - School |
| Location | 3200 23rd Ave S, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194205963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SS0200X | Clinical Nurse Specialist - School | RN60178621 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Stephanie Michelle Pizarro, RN 2803 14th Ave S, Seattle, WA 98144-5716 Ph: (206) 909-3265 | Mrs Stephanie Michelle Pizarro, RN 3200 23rd Ave S, Seattle, WA 98144-6432 Ph: (206) 252-7285 |
News Archive
The worldwide safety experience of endoscopist-administered propofol sedation now exceeds 600,000 patients. The low rate of serious adverse events underscores the safety of nonanesthesiologist-administered propofol (NAAP) for gastrointestinal (GI) procedures, provided that it is administered by a team of individuals who have received training specific to the administration of propofol according to the "Position statement: nonanesthesiologist administration of propofol for GI endoscopy" issued by the four major gastroenterology and hepatology societies.
A UMass Lowell researcher has been awarded a $2.48 million grant to develop advances in safety for home care aides and clients that will keep pace with an aging population, advances in technology and other factors that are rapidly changing the field.
A review of more than 20 studies by researchers at Arizona State University and the Translational Genomics Research Institute, an affiliate of City of Hope, suggests that nonalcoholic fatty-liver disease (NAFLD) is a growing dietary problem for children across the globe.
A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that redirects blood flow away from wide-necked or giant aneurysms that cannot be treated in more conventional ways.
› Verified 6 days ago
Ms. Laura C Heard, RN, MS, CRRN-A Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1660 S Columbian Way, #128, Seattle, WA 98108 Phone: 206-277-3302 Fax: 206-764-2799 | |
Michelle Dedeo, DNP, ARNP-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 500 17th Ave, Seattle, WA 98122 Phone: 425-659-3141 | |
Dr. Brian Burns, ARNP-CS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-8811 | |
Ms. Janet Marie Rhode, ARNP, MN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 11339 8th Ave Ne, Seattle, WA 98125 Phone: 206-366-1771 Fax: 206-365-0827 | |
Megan Stimpson, PCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-9976 | |
Ms. Melanie Jones Markle, A.R.N.P. Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2021 Minor Ave E # 8, #8, Seattle, WA 98102 Phone: 206-324-0315 Fax: 206-324-4680 |